Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Identification of miR-143-3p as a diagnostic biomarker in gastric cancer

Fig. 3

Expression levels of 13 differentially expressed miRNAs and receiver operating characteristic curve analysis of 13 differentially expressed miRNAs of gastric cancer tissues vs. adjacent non-tumor tissues in the validation set. miRNAs upregulated in gastric cancer were a miR-34c, b miR-423, c miR-500b, d miR-542, e. miR-1228, and f. miR-3687. miRNAs downregulated in gastric cancer were g miR-30a, h miR-133a-1, i miR-133a-2, j miR-133b, k miR-139, l miR-143, and m miR-195. The area under the receiver operating characteristic curve values were calculated to estimate the diagnostic performance of the differentially expressed miRNAs in gastric cancer. Data are expressed as the means ± standard deviations (SDs). *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page